Interferon β improves the efficacy of low dose cisplatin by inhibiting NF-κB/p-Akt signaling on HeLa cells. [electronic resource]
Producer: 20170207Description: 124-32 p. digitalISSN:- 1950-6007
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Nucleus -- drug effects
- Cell Proliferation -- drug effects
- Cisplatin -- pharmacology
- Dose-Response Relationship, Drug
- Drug Synergism
- HeLa Cells
- Humans
- I-kappa B Proteins -- metabolism
- Interferon-beta -- pharmacology
- Matrix Metalloproteinase 9 -- metabolism
- Micronucleus, Germline -- drug effects
- NF-kappa B -- metabolism
- Phosphorylation -- drug effects
- Poly(ADP-ribose) Polymerases -- metabolism
- Proto-Oncogene Proteins c-akt -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- STAT2 Transcription Factor -- metabolism
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.